Verici Dx plc (LON:VRCI – Get Free Report)’s share price traded down 14.7% during trading on Thursday . The stock traded as low as GBX 1.07 ($0.01) and last traded at GBX 1.07 ($0.01). 506,862 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 1,088,881 shares. The stock had previously closed at GBX 1.25 ($0.02).
Verici Dx Price Performance
The company has a market capitalization of £4.19 million, a PE ratio of -0.80 and a beta of 1.59. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49. The company’s 50 day simple moving average is GBX 1.82 and its 200 day simple moving average is GBX 2.82.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
See Also
- Five stocks we like better than Verici Dx
- How to buy stock: A step-by-step guide for beginners
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- P/E Ratio Calculation: How to Assess Stocks
- 3 Trades Members of Congress Are Making Right Now
- Insider Trading – What You Need to Know
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
